Effects of Vitamin C in Prevention of Atrial Fibrillation after coronary artery bypass graft (CABG)
Phase 2
- Conditions
- Coronary Artery Disease.Atherosclerotic heart disease
- Registration Number
- IRCT201207243799N3
- Lead Sponsor
- Tehran University of Medical Sciences Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
Inclusion Criteria: Patients with coronary artery disease (on angiography) who are candidate for coronary artery bypass.
Exclusion Criteria
1- Patients above 80 years old. 2- Patients who have Atrial Fibrillation before surgery. 3- Patients with heart valve disease or arrhythmia or having every degree of heart block conduction. 4- Patients who use a pacemaker. 5- Patients who have chronic lung, liver or kidney disease. 6- Patients who have other heart surgeries simultaneously with bypass surgery. 7- History of using anti-arrhythmic drugs. 8- Having sick sinus syndrome. 9- Having symptoms of urinary stone or history of kidney stones. 10- History of using Vitamin C in the recent quarter.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of hospital stay. Timepoint: At discharge time. Method of measurement: Refer to the Patient file.;AF rhythm. Timepoint: Continuous monitoring for the first 72 hours after CABG surgery and then daily ECG. Method of measurement: ECG recording device.;Length of stay in ICU. Timepoint: At the time of transferring to the ward. Method of measurement: Refer to the data sheet in ICU.
- Secondary Outcome Measures
Name Time Method